The French National Cochlear Implant Registry (EPIIC): Cochlear explantation and reimplantation.


Journal

European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 23 8 2020
medline: 9 9 2021
entrez: 23 8 2020
Statut: ppublish

Résumé

This study aims to determine the frequency and causes of cochlear explants with re-implantation (ERI) after 5 years' follow up of the patients included in the French national EPIIC (étude post-inscription des implants cochléaires) registry tracking patients with cochlear implantation. This multicenter, descriptive prospective study was conducted on 5051 patients enrolled in the EPIIC database between January 2012 and December 2016. Ninety-five patients (1.9%) received a primary implant and an ERI during the study. Of these, four benefitted from two ERIs. The number of ERIs was significantly higher in the pediatric population than among adults. The explantation and reimplantation were performed simultaneously in 86% of cases. The reasons for explantation were: in 46.4% of cases linked to a malfunction of the implant, and in 39.3% of cases for medical or surgical reasons. The number of electrodes inserted was significantly higher after the ERI than after the first implantation. There was just one post-ERI infection for these 95 explanted and re-implanted patients. As well as explantation with reimplantation rarely being necessary, it generally presents no major surgical difficulty and in most cases it allows a better integration than in the first implantation.

Identifiants

pubmed: 32826202
pii: S1879-7296(20)30172-1
doi: 10.1016/j.anorl.2020.07.006
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

S45-S49

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

R Hermann (R)

Otorhinolaryngology department and Head and Neck Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.

A Coudert (A)

Otorhinolaryngology department and Head and Neck Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.

K Aubry (K)

CHU de Limoges, Limoges, France.

P Bordure (P)

CHU de Nantes, Nantes, France.

A Bozorg-Grayeli (A)

CHU de Dijon, Dijon, France.

O Deguine (O)

CHU de Toulouse, Toulouse, France.

C Eyermann (C)

CHU de Strasbourg, Strasbourg, France.

V Franco-Vidal (V)

CHU de Bordeaux, Bordeaux, France.

B Godey (B)

CHU de Rennes, Rennes, France.

N Guevara (N)

CHU de Nice, Nice, France.

A Karkas (A)

CHU de St Etienne, Saint-Etienne, France.

N Klopp (N)

CHU d'Amiens, Amiens, France.

M Labrousse (M)

CHU de Reims, Reims, France.

J-P Lebreton (JP)

CHU de Poitiers, Poitiers, France.

Y Lerosey (Y)

CHU de Rouen, Rouen, France.

E Lescanne (E)

CHU de Tours, Tours, France.

N Loundon (N)

Hôpital Necker, Paris, France.

R Marianowski (R)

CHU de Brest, Brest, France.

F Merklen (F)

CHU de Montpellier, Montpellier, France.

K Mezouaghi (K)

CH de La Réunion, La Réunion, France.

T Mom (T)

CHU de Clermont-Ferrand, Clermont-Ferrand, France.

S Moreau (S)

CHU de Caen, Caen, France.

I Mosnier (I)

Hôpital Pitié-Salpétrière, Paris, France.

N Noël-Petroff (N)

Hôpital Robert-Debré, Paris, France.

C Parietti-Winkler (C)

CHU de Nantes, Nantes, France.

P Piller (P)

CH de Nouméa, Nouméa, Nouvelle-Calédonie.

C Poncet (C)

Hôpital Rothschild, Paris, France.

E Radafy (E)

CH du Lamentin, Martinique, France.

S Roman (S)

CHU de Marseille, Marseille, France.

S Roux-Vaillard (S)

CHU d'Angers, Angers, France.

S Schmerber (S)

CHU de Grenoble, La Tronche, France.

L Tavernier (L)

CHU de Besançon, Besançon, France.

C Vincent (C)

CHU de Lille, Lille, France.

E Truy (E)

Otorhinolaryngology department and Head and Neck Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France. Electronic address: eric.truy@chu-lyon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH